参考文献/References:
[1] 董晓雪杨栋王汉斌等. 左心耳结构数据测量方法应用于经皮左心耳封堵术的研究进展[J]. 中国介入心脏病学杂志,2016(6):351-353.
[2] January CT,Wann LS,Alpert JS,et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation,2014,130(23):2071-2104.
[3] Beinart R,Heist EK,Newell JB,et al. Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation[J]. J Cardiovasc Electrophysiol,2011,22(1):10-15.
[4] 黄从新,张澍,黄德嘉,等. 心房颤动:目前的认识和治疗建议(2018)[J]. 中华心律失常学杂志,2018,22(4):279-346.
[5] Chiang CE,Okumura K,Zhang S,et al. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation[J].J Arrhythm,2017,33(4):345-367.
[6] 苏晞.左心耳封堵治疗的最新研究进展[J]. 实用医院临床杂志,2017,(1): 9-12.
[7] Chang SS,Dong JZ,Ma CS,et al. Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study[J]. Stroke,2016,47(7):1803-1810.
[8] Wang ZZ,Du X,Wang W,et al. Long-term persistence of newly initiated warfarin therapy in Chinese patients with nonvalvular atrial fibrillation[J]. Circ Cardiovasc Qual Outcomes,2016,9(4):380-387.
[9] 熊婧,陈维. 经皮左心耳封堵术研究回顾与展望[J]. 中国介入心脏病学杂志, 2018, 26(10):589-592.
[10] Reddy VY,Sievert H,Halperin J,et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation:a randomized clinical trial[J]. JAMA,2014,312(19):1988-1998.
[11] Reddy VY,Holmes D,Doshi SK,et al. Safety of percutaneous left atrial appendage closure:results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF(PROTECT AF) clinical trial and the Continued Access Registry[J]. Circulation,2011,123(4):417-424.
[12] Reddy VY,Mobius-Winkler S,Miller MA,et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation:the ASAP study(ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)[J]. J Am Coll Cardiol,2013,61(25):2551-2556.
[13] Holmes DJ,Kar S,Price MJ,et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy:the PREVAIL trial[J]. J Am Coll Cardiol,2014, 64(1):1-12.
[14] Bajaj NS,Parashar A,Agarwal S,et al. Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation:a systematic review and analysis of observational studies[J]. JACC Cardiovasc Interv,2014,7(3):296-304.
[15] Holmes DJ,Doshi SK,Kar S,et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis[J]. J Am Coll Cardiol,2015,65(24):2614-2623.
[16] Zhou X,Zhang W,Lv W,et al. Left atrial appendage occlusion in atrial fibrillation for stroke prevention:a systemic review[J]. Int J Cardiol,2016,203(10): 55-59.
[17] 中华医学会心电生理和起搏分会,中华医学会心血管病学分会,中国医师协会心律学专业委员会. 左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议[J]. 中华心律失常学杂志,2014,18(6):401-415.
[18] Tabata T,Oki T,Yamada H,et al. Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide[J]. Eur J Echocardiogr,2000,1(2):130-137.
[19] di Biase L,Burkhardt JD,Mohanty P,et al. Left atrial appendage:an underrecognized trigger site of atrial fibrillation[J]. Circulation,2010,122(2):109-118.
[20] Yamada T,Mcelderry HT,Allison JS,et al. Focal atrial tachycardia originating from the epicardial left atrial appendage[J]. Heart Rhythm,2008,5(5):766-767.
[21] Dar T,Afzal MR,Yarlagadda B,et al. Mechanical function of the left atrium is improved with epicardial ligation of the left atrial appendage:insights from the LAFIT-LARIAT Registry[J]. Heart Rhythm,2018,15(7):955-959.
[22] Nishikimi T,Maeda N,Matsuoka H. The role of natriuretic peptides in cardioprotection[J]. Cardiovasc Res,2006,69(2):318-328.
[23] Volpe M. Natriuretic peptides and cardio-renal disease[J]. Int J Cardiol,2014,176(3):630-639.
[24] 亢扬. 心力衰竭患者血浆B型利钠肽/氨基末端利钠肽原水平正常的研究进展[J]. 心血管病学进展,2018,39(4):622-626.
[25] Santhekadur PK,Kumar DP,Seneshaw M,et al. The multifaceted role of natriuretic peptides in metabolic syndrome[J]. Biomed Pharmacother,2017,92(8):826-835.
[26] de Bold AJ,Bruneau BG,Kuroski DBM. Mechanical and neuroendocrine regulation of the endocrine heart[J]. Cardiovasc Res,1996,31(1):7-18.
[27] Tabata T,Oki T,Yamada H,et al. Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide[J]. Eur J Echocardiogr,2000,1(2):130-137.
[28] Rodeheffer RJ,Naruse M,Atkinson JB,et al. Molecular forms of atrial natriuretic factor in normal and failing human myocardium[J]. Circulation,1993, 88(2):364-371.
[29] 佘飞,刘书旺,郭丽君. 左心耳封堵术在心房颤动患者中的应用价值[J]. 中国心血管杂志,2013,(6):409-411.
[30] 高虹,杨波,叶距亨,等. 左心耳封堵术对非瓣膜性心房颤动患者心功能和神经内分泌功能的影响[J]. 中华生物医学工程杂志,2017(1):37-40.
[31] Naya T,Yukiiri K,Hosomi N,et al. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation[J]. Cerebrovasc Dis,2008,26(4):434-440.
[32] Majunke N,Sandri M,Adams V,et al. Atrial and brain natriuretic peptide secretion after percutaneous closure of the left atrial appendage with the Watchman device[J]. J Invasive Cardiol,2015,27(10):448-452.
[33] Lakkireddy D,Turagam M,Afzal MR,et al. Left atrial appendage closure and systemic homeostasis:The LAA HOMEOSTASIS study[J]. J Am Coll Cardiol,2018, 71(2):135-144.
相似文献/References:
[1]安硕研,郑金刚.左心耳封堵术预防心源性卒中的进展[J].心血管病学进展,2019,(6):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]
AN Shuoyan,ZHENG Jingang.Left Atrial Appendage Closure for Prevention of Cardiogenic Stroke[J].Advances in Cardiovascular Diseases,2019,(6):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]
[2]朱世杰,郑慕晗,张建武,等.心脏CT在左心耳封堵术中的应用价值[J].心血管病学进展,2020,(1):11.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.004]
ZHU Shijie,ZHENG Muhan,ZHANG Jianwu,et al.Application of Cardiac CT in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2020,(6):11.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.004]
[3]李亚会 黄从新.左心耳封堵术常见并发症及其防治[J].心血管病学进展,2021,(5):408.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.006]
LI YahuiHUANG Congxin.Common Complications of Left Atrial Appendage Occlusion and Its Prevention and Treatment[J].Advances in Cardiovascular Diseases,2021,(6):408.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.006]
[4]吴阳 杨桂荣 张波 陈各才.双源CT在左心耳封堵术前评估及指导选择WatchmanTM封堵器型号的应用[J].心血管病学进展,2021,(4):374.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.020]
WU Yang,YANG Guirong,ZHANG Bo,et al.The Application of Dual Source CT in Preoperative Evaluation of Left Atrial Appendage Occlusion and Size Selection of Watchman TM Occluder.com[J].Advances in Cardiovascular Diseases,2021,(6):374.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.020]
[5]柏懿璇 崔凯军.左心耳封堵术后装置相关血栓[J].心血管病学进展,2022,(5):407.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.006]
BAI Yixuan,CUI Kaijun.Device-Related Thrombus After Left Atrial Appendage Occlusion[J].Advances in Cardiovascular Diseases,2022,(6):407.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.006]
[6]王璐 李耀东.TAVR合并心房颤动抗凝策略的研究进展[J].心血管病学进展,2022,(8):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
WANG Lu,LI Yaodong.Anticoagulation Strategy in Patients After TAVR Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(6):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
[7]魏志梁 孙雨可 尹月娇 孙守刚.心房颤动合并慢性肾脏病患者的左心耳封堵治疗研究进展[J].心血管病学进展,2022,(9):783.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
WEI Zhiliang,SUN Yuke,YIN Yuejiao,et al.Left Atrial Appendage Closure in Patients with Atrial Fibrillation Complicated with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2022,(6):783.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
[8]加依娜·加尔肯 汤宝鹏 周贤惠 李耀东 芦颜美.非瓣膜性心房颤动患者“一站式”手术策略的有效性和安全性:单中心经验[J].心血管病学进展,2022,(12):1141.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.019]
Jiayina Jiaerken,TANG Baopeng,ZHOU Xianhui,et al.Effectiveness and Safety of "One-Step" Procedure in Patients with Non-Valvular Atrial Fibrillation:A Single Center Experience?/html>[J].Advances in Cardiovascular Diseases,2022,(6):1141.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.019]
[9]许溪麟 李小明.艾多沙班在心血管疾病应用的研究进展[J].心血管病学进展,2024,(5):451.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.016]
XU Xilin,LI Xiaoming.Application of Edoxaban in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(6):451.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.016]
[10]金铁托 阮中宝.左心耳封堵术对患者系统内稳态的影响[J].心血管病学进展,2020,(12):1268.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.011]
JIN Tietuo,RUAN Zhongbao.Effect of Left Atrial Appendage Closure on Systemic Homeostasis in Patients[J].Advances in Cardiovascular Diseases,2020,(6):1268.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.011]
[11]邓蕊 李洪仕 蔡衡.左心耳封堵术对非瓣膜性心房颤动合并冠状动脉性心脏病的价值[J].心血管病学进展,2022,(11):966.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.002]
DENG Rui,LI Hongshi,CAI Heng.Value of Left Atrial Appendage Closure on Non-Valvular Atrial Fibrillation with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2022,(6):966.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.002]
[12]秦可隽?姜述斌.左心耳封堵术对非瓣膜性心房颤动患者左心功能影响的研究进展[J].心血管病学进展,2024,(5):425.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.010]
QIN KejuanJIANG Shubin.Effects of Left Atrial Appendage Closure on Left Heart Function in Patients with Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2024,(6):425.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.010]